Specific receptors in the immune cells detect and generate responses to defend against the virus that causes COVID-19—SARS-COV-2—when it infects the body, according to University of Maine immunology expert Mumtaz Yaseen ...
May 13, 2021
0
7
More than a year into the pandemic, the World Health Organization (WHO) and US Centers for Disease Control finally changed their guidance to acknowledge SARS-CoV-2, the virus that causes COVID-19, can be transmitted through ...
May 13, 2021
0
4
Severe symptoms of COVID-19, leading often to death, are thought to result from the patient's own acute immune response rather than from damage inflicted directly by the virus. Immense research efforts are therefore invested ...
May 12, 2021
0
93
The virostatic agent remdesivir was developed to disrupt an important step in the propagation of RNA viruses, to which SARS-CoV-2 also belongs: the reproduction of the virus's own genetic material. This is present as RNA ...
May 10, 2021
0
4
A potential new vaccine developed by members of the Duke Human Vaccine Institute has proven effective in protecting monkeys and mice from a variety of coronavirus infections—including SARS-CoV-2 as well as the original ...
May 10, 2021
0
590
German firm BioNTech said Monday that the COVID-19 vaccine it developed with Pfizer does not require any modifications to work against variants of the virus, as it announced new plans to ramp up production of the jabs.
May 10, 2021
0
6
Two doses of BNT162b2 are highly effective for preventing symptomatic and asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections and other outcomes, according to a study published online May ...
May 7, 2021
0
6
New research published in Experimental Physiology highlight the possible long term health impacts of COVID-19 on young, relatively healthy adults who were not hospitalized and who only had minor symptoms due to the virus.
May 6, 2021
0
17
The SARS-CoV-2 pandemic's acute effects on people's lives has appropriately held the nation's attention, but the long-term effects that many people suffer is garnering increasing attention. Now officially termed Post-Acute ...
May 6, 2021
0
0
The United Kingdom government plans to implement mass scale population testing for SARS-CoV-2 infection using Lateral Flow Devices (LFDs), yet the devices' sensitivity is unknown. A study published in the open access journal ...
Apr 29, 2021
0
9
